Dr. Kazuaki Takabe

Dr. Kazuaki Takabe, MD, PhD, FACS, is a prominent surgical oncologist and physician-scientist widely regarded for his contributions to the treatment and understanding of breast cancer. He serves as the Clinical Chief of Breast Surgery and the Alfiero Foundation Endowed Chair in Breast Oncology at Roswell Park Comprehensive Cancer Center, where he leads a multidisciplinary team focused on delivering cutting-edge cancer care. Dr. Takabe earned his medical degree and PhD in oncology from Yokohama City University in Japan and completed surgical training at multiple esteemed institutions, including the University of Texas Medical Branch and Virginia Commonwealth University.

Internationally recognized for his research in cancer immunology and tumor biology, Dr. Takabe has developed a highly productive laboratory investigating the molecular mechanisms that drive breast cancer progression and immune evasion. His work has contributed to the identification of novel biomarkers and therapeutic targets, with numerous publications in leading peer-reviewed journals. As a clinician, he is renowned for his skill in advanced surgical procedures and for integrating translational science into individualized treatment strategies. He remains a champion of using both precision oncology and immunotherapeutic approaches to improve survival and quality of life for patients.

Beyond his clinical and scientific achievements, Dr. Takabe is a devoted mentor and educator to medical students, surgical residents, and fellows. He holds leadership roles in national and international organizations, including the Society of Surgical Oncology and the American Society of Clinical Oncology, where he promotes collaboration and innovation across disciplines. With a career marked by academic excellence, pioneering research, and a steadfast commitment to patient-centered care, Dr. Takabe continues to shape the future of breast cancer treatment and translational oncology.